Widening use of dexamethasone implant for the treatment of macular edema

Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolyme...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Drug Des Devel Ther
Hoofdauteurs: Bonfiglio, Vincenza, Reibaldi, Michele, Fallico, Matteo, Russo, Andrea, Pizzo, Alessandra, Fichera, Stefano, Rapisarda, Carlo, Macchi, Iacopo, Avitabile, Teresio, Longo, Antonio
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Dove Medical Press 2017
Onderwerpen:
Review
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566324/
https://ncbi.nlm.nih.gov/pubmed/28860707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S138922
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items